Edgar Engleman, Director, 10% Owner at Bolt Biotherapeutics, Inc. (BOLT), sold 164 shares at $20.00 ($3K) on 2021-02-09, disclosed to the SEC on 2021-02-09.
Open-market sale of $3k BOLT by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.00 | 20 | $400 | 12.2% |
| 2 | $20.00 | 144 | $3K | 87.8% |
| Total | $20.00 avg | 164 | $3K | 100% |
| Filing → |
| BOLT | SELL | 2023-11-20 | $46K | — | Filing → |
| SLNO | BUY | 2017-12-19 | $4.0M | — | Filing → |
| CAPN | BUY | 2017-04-14 | $2.7M | — | Filing → |